Back to today’s briefing

Story perspectives

Patient Sues Novo Nordisk Over Ozempic Side Effects

4/5/2025

48 11

Summary

Story summary

Wilson is taking legal action against Novo Nordisk, alleging that Ozempic, prescribed for her type 2 diabetes, led to debilitating gastrointestinal problems like gastroparesis. She accuses the company of negligence and failing to adequately warn patients about these risks. Her lawsuit will be part of a larger group of GLP-1 cases in Pennsylvania, where pivotal trials will explore crucial legal issues before any possible settlements.

1 of 1

Story summary

Wilson is taking legal action against Novo Nordisk, alleging that Ozempic, prescribed for her type 2 diabetes, led to debilitating gastrointestinal problems like gastroparesis. She accuses the company of negligence and failing to adequately warn patients about these risks. Her lawsuit will be part of a larger group of GLP-1 cases in Pennsylvania, where pivotal trials will explore crucial legal issues before any possible settlements.